At a glance
- Originator Innothera
- Class Cardiotonics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 20 Jan 2017 Discontinued - Phase-II for Heart failure (unspecified route)
- 29 May 1998 Suspended-II for Heart failure (Unknown route)